Cinobufotalin
Based on 6 publication(s) in Google Scholar
Cinobufotalin is a cardiotonic steroids or bufadienolides, is extracted from the skin secretions of the giant toads. Cinobufotalin has been used as a cardiotonic, diuretic and a hemostatic agent, Cinobufotalin is also a potential anti-lung cancer agent.
For research use only. We do not sell to patients.
- Purity: 99.82%
- CAS No.: 1108-68-5
- Formula: C26H34O7
- Molecular Weight:458.54
-
Storage:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
Publications Citing Use of MedChemExpress (MCE) Cinobufotalin
More- J Adv Res. 2026 Feb 21:S2090-1232(26)00180-3. [Abstract]
- Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
- Pharmacol Res. 2021 Dec:174:105927. [Abstract]
- Phytomedicine. 2024 Jan:123:155169. [Abstract]
- Eur J Pharmacol. 2021 Sep 5:906:174280. [Abstract]
- J Cell Mol Med. 2025 Aug;29(16):e70788. [Abstract]
-
In Vivo Efficacy Study
-
Flow Cytometry
-
Flow Cytometry
-
WB
-
RT-PCR
Biological Activity
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| Bel-7402 | IC50 |
1.21 μM
Compound: 4
|
Cytotoxicity against human Bel7402 cells by MTT assay
Cytotoxicity against human Bel7402 cells by MTT assay
|
[PMID: 18558746] |
| Bel-7402 | IC50 |
8.62 μM
Compound: M-2, 5-HCB
|
Cytotoxicity against human Bel7402 cells assessed as againsthibition of cell growth after 72 hrs
Cytotoxicity against human Bel7402 cells assessed as againsthibition of cell growth after 72 hrs
|
[PMID: 21205911] |
| HL-60 | IC50 |
0.047 μg/mL
Compound: 14
|
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
Cytotoxicity against human HL60 cells after 72 hrs by MTT assay
|
[PMID: 11575946] |
| KB | IC50 |
0.37 μg/mL
Compound: 14
|
Cytotoxicity against human KB cells after 72 hrs by MTT assay
Cytotoxicity against human KB cells after 72 hrs by MTT assay
|
[PMID: 11575946] |
| MH60 | IC50 |
>25 μg/mL
Compound: 14
|
Cytotoxicity against mouse MH60 cells after 72 hrs by MTT assay
Cytotoxicity against mouse MH60 cells after 72 hrs by MTT assay
|
[PMID: 11575946] |
Cinobufotalin (0.1-10 μM; 72 hours; A549, H460 and HTB-58 human lung cancer cells) treatment induces cytotoxic effect against lung cancer cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A549, H460 and HTB-58 human lung cancer cells
-
Concentration:0.1 µM, 0.5 µM, 1 µM, 5 µM, 10 µM
-
Incubation Time:72 hours
-
Result:Significantly induced cell death in a concentration-dependent manner.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Male nude mice (4-6 weeks old, BALB/c) with A549 cells[1]
-
Dosage:1 mg/kg or 5 mg/kg
-
Administration:Intraperitoneal injection; twice daily; for 1 weeks
-
Result:Inhibited A549 lung cancer cell growth in vivo.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 1108-68-5
-
Appearance Solid
-
Molecular Weight 458.54
-
Formula C26H34O7
-
Color White to off-white
-
SMILES
C[C@]([C@@H](C(C=C1)=COC1=O)[C@H]2OC(C)=O)(CC[C@@]3([H])[C@@]4([H])CC[C@@]5(O)[C@@]3(CC[C@H](O)C5)C)[C@@]64[C@@H]2O6
-
Structure Classification
-
Initial Source
toad
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Powder -20°C 3 years 4°C 2 years In solvent -80°C 2 years -20°C 1 year
Publications (6)
-
Journal Impact Factor
-
Most Recent
-
J Adv Res
Lactobacillus plantarum AR113 alleviates Western Diet-Induced colitis and liver injury via bidirectional modulation of the Intestinal-Hepatic FXR signaling axis. [Abstract]2026 Feb 21:S2090-1232(26)00180-3. PMID: 41730412 -
Cell Death Dis
Targeting PPARγ via SIAH1/2-mediated ubiquitin-proteasomal degradation as a new therapeutic approach in luminal-type bladder cancer. [Abstract]2024 Dec 18;15(12):908. PMID: 39695138
Cinobufotalin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
Tumor sizes were measured every 2 days during treatment with cinobufotalin (1 and 5 mg/kg, ip, qd) or cisplatin.
Cinobufotalin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
Effects of cinobufotalin (0-1.25 μM) on cell cycle distribution in RT112 cells. Cells were treated with different concentrations of cinobufotalin for 48 h and subsequently stained using propidium iodide. The cell cycle was analysed via flow cytometry.
Cinobufotalin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
Effect of cinobufotalin (0-1.25 μM) on apoptosis in RT112 cells. Cells were treated with varying concentrations of cinobufotalin for 48 h, stained with Annexin V/7-AAD, and analysed via flow cytometry.
Cinobufotalin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
RT112 cells were treated with the indicated concentrations of cinobufotalin (0-1.25 μM) for 24 h and 48 h and expression of proteins analysed via western blot. Band intensities of each protein were quantified using Image J and normalized to GAPDH.
Cinobufotalin purchased from MedChemExpress. Usage Cited in: Cell Death Dis. 2024 Dec 18;15(12):908. [Abstract]
Effects of cinobufotalin (0-1.25 μM) on mRNA levels of PPARγ and its downstream target genes in RT112 cells. Cells were treated with the indicated concentrations of cinobufotalin for 24 h and mRNA expression determined via RT-qPCR.
-
Pharmacol Res
2021 Dec:174:105927. PMID: 34740818 -
Phytomedicine
Compound-composed Chinese medicine of Huachansu triggers apoptosis of gastric cancer cells through increase of reactive oxygen species levels and suppression of proteasome activities. [Abstract]2024 Jan:123:155169. PMID: 37992493 -
Eur J Pharmacol
Novel SREBP1 inhibitor cinobufotalin suppresses proliferation of hepatocellular carcinoma by targeting lipogenesis. [Abstract]2021 Sep 5:906:174280. PMID: 34174265 -
J Cell Mol Med
Cinobufotalin Ameliorates the Development of Pulmonary Fibrosis by Suppressing the TGF-β/Smad Pathway via Regulating PI15. [Abstract]2025 Aug;29(16):e70788. PMID: 40845143
Solvent & Solubility
DMSO : 87.5 mg/mL (190.82 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.17 mg/mL (4.73 mM); Clear solution
This protocol yields a clear solution of ≥ 2.17 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (21.7 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.17 mg/mL (4.73 mM); Clear solution
This protocol yields a clear solution of ≥ 2.17 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (21.7 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Purity & Documentation
-
Data Sheet (278 KB)
-
SDS (481 KB)
- English - EN (481 KB)
- Français - FR (481 KB)
- Deutsch - DE (481 KB)
- Norwegian - NO (481 KB)
- Español - ES (481 KB)
- Swedish - SV (481 KB)
- Italian - IT (481 KB)
- Korean - KR (481 KB)
- Portuguese - PT (481 KB)
-
Handling Instructions (2659 KB)
References
[1]. Kai S, et al. Pre-clinical evaluation of cinobufotalin as a potential anti-lung cancer agent. Biochem Biophys Res Commun. 2014 Sep 26;452(3):768-74. [Content Brief]
[2]. Li C, Guo H, Wang C, et al. Network pharmacological mechanism of Cinobufotalin against glioma. Prog Brain Res. 2021;265:119-137. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 2 years; -20°C, 1 year. When stored at -80°C, please use it within 2 years. When stored at -20°C, please use it within 1 year.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.1808 mL | 10.9042 mL | 21.8083 mL | 54.5209 mL |
| 5 mM | 0.4362 mL | 2.1808 mL | 4.3617 mL | 10.9042 mL | |
| 10 mM | 0.2181 mL | 1.0904 mL | 2.1808 mL | 5.4521 mL | |
| 15 mM | 0.1454 mL | 0.7269 mL | 1.4539 mL | 3.6347 mL | |
| 20 mM | 0.1090 mL | 0.5452 mL | 1.0904 mL | 2.7260 mL | |
| 25 mM | 0.0872 mL | 0.4362 mL | 0.8723 mL | 2.1808 mL | |
| 30 mM | 0.0727 mL | 0.3635 mL | 0.7269 mL | 1.8174 mL | |
| 40 mM | 0.0545 mL | 0.2726 mL | 0.5452 mL | 1.3630 mL | |
| 50 mM | 0.0436 mL | 0.2181 mL | 0.4362 mL | 1.0904 mL | |
| 60 mM | 0.0363 mL | 0.1817 mL | 0.3635 mL | 0.9087 mL | |
| 80 mM | 0.0273 mL | 0.1363 mL | 0.2726 mL | 0.6815 mL | |
| 100 mM | 0.0218 mL | 0.1090 mL | 0.2181 mL | 0.5452 mL |